Blevins Brothers Fortnite Charity Event at Michigan Stadium Raises Over $90,000 for Cancer Research

Author | Sam Page

Ninja and BeardedBlevins stand on the field at Michigan Stadium.

The Blevins Brothers—Ninja and BeardedBlevins—raised $93,125 for the University of Michigan Health Rogel Cancer Center by playing Fortnite live from Michigan Stadium.

Michigan natives and world-famous video game streamers, the brothers broadcast on Twitch for over five hours, garnering hundreds of thousands of views and 650 donations. 

“I want to thank everyone who helped put this incredible event together, along with the companies and members of our communities who generously donated,” said Tyler Blevins, better known as Ninja.

“It’s amazing to raise nearly $100,000 for cancer research in five hours, but it’s even better to know that you’re giving it to the right place doing the right work.”

During the visit, Ninja and BeardedBlevins streamed with a rotating cast of special U-M guests, including Wolverine quarterbacks Davis Warren and Alex Orji, San Francisco 49ers kicker Jake Moody, Olympic bronze medalist Paul Juda, and the U-M men’s basketball team’s Danny Wolf. 

The donated funds, which will be used to support the Rogel Cancer Center’s innovative research, were made possible by matching sponsors Alro Steel, Domino’s, and Michigan Mudbowl—and the support of in-kind sponsors PowerGPU, Nvidia, and Team Ninja. Amazon sponsored the guest chair.

The streamers also toured labs within the Rogel Center, spoke with researchers and heard stories about how the work they were supporting leads to the prevention, diagnosis and treatment of cancer.

“It was a great pleasure hosting a lab tour to show Ninja and BeardedBlevins how our research team studies skin cancer in the Rogel Cancer Center,” said Andrzej Dlugosz, M.D., the center’s Associate Director for Basic Science Research.

“The goal of our work is to understand the cause of these cancers and discover more effective ways to treat or prevent them.”

As top-ranked health care providers in the nation, Michigan Medicine and the Rogel Cancer Center are leading efforts to generate new knowledge and advance research to transform cancer prevention and treatment. 

“Working with the University of Michigan Health Rogel Cancer Center has been an absolute honor,” said Jonathan Blevins, aka BeardedBlevins.

“I was blown away by all of the life-changing work that everyone in that building is doing. They shared some miraculous stories with us, and I will never forget those few hours. I can't wait to continue to support the work they are doing. Go Blue!”


More Articles About:

Rogel Cancer Center

Featured News & Stories

Stephen and Faith Brown standing together next to a huge bell at the top of Burton Memorial Tower.
Philanthropy News

Long friendship inspires urology resident fund

U-M alumni Stephen and Faith Brown have created a fund to expand research and travel opportunities for urology residents in the U-M Medical School.
close up of cells blue purple pink
Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
Portrait of Rose Page. She has short black hair and is wearing a sleeveless white blouse. She is smiling and turned 45 degrees to the right of the viewer.
Philanthropy News

Gifts advance colon cancer prevention and early detection

The Rose and Lawrence C. Page, Sr. Family Charitable Foundation supports lifesaving colon cancer research at Michigan Medicine.
purple yellow red cells up close
Health Lab

Study explains how colorectal cancer cells maintain high iron levels

How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
couple with 3 dogs on porch smiling
Health Lab

Receiving personalized treatment for a rare neuroendocrine tumor

Danielle Schuldt was diagnosed with a rare endocrine tumor and underwent surgery as part of her treatment. She now undergoes regular surveillance to monitor for cancer recurrence.
woman touching her neck in robe at home
Health Lab

Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers

University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.